Idiopathic Pulmonary Fibrosis News

Pulmonary Fibrosis Foundation Launches Partnership With Inspire Online Support ... - MarketWatch (press release)



Pulmonary Fibrosis Foundation Launches Partnership With Inspire Online Support ... 
MarketWatch (press release)
About the Pulmonary Fibrosis FoundationThe mission of the Pulmonary Fibrosis Foundation (PFF) is to help find a cure for idiopathic pulmonary fibrosis (IPF), advocate for the pulmonary fibrosis community, promote disease awareness, and provide a ...

and more » 


Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive ... - MarketWatch (press release)



Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive ... 
MarketWatch (press release)
Dr. Bruhn takes on the role of CEO at a time when Promedior is rapidly advancing its product candidates in human clinical trials for diseases involving fibrosis, including idiopathic pulmonary fibrosis (IPF), myelofibrosis, and retinal diseases.

and more » 


Pulmatrix Announces Presentations at ATS 2012 International Conference - PharmaLive.com (press release)



Pulmatrix Announces Presentations at ATS 2012 International Conference 
PharmaLive.com (press release)
... in these posters will include both clinical and preclinical data that highlight the potential of iCALM and iSPERSE drug candidates for respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis (CF).
Pulmatrix Demonstrates iSPERSE Capabilities for Inhaled Dry Powder Delivery of ... MarketWatch (press release)

all 9 news articles » 


FibroGen Expands Clinical Study Based on Preliminary Data Indicating ... - MarketWatch (press release)



FibroGen Expands Clinical Study Based on Preliminary Data Indicating ... 
MarketWatch (press release)
... expansion of an ongoing open-label Phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF).

and more » 


June 3 Memorial Golf Tournament Benefits Pulmonary Fibrosis Research - University of Rochester Newsroom



University of Rochester Newsroom
 
June 3 Memorial Golf Tournament Benefits Pulmonary Fibrosis Research 
University of Rochester Newsroom
Idiopathic pulmonary fibrosis is diagnosed when lung tissue becomes thickened, stiff, and scarred. The development of the scar tissue is called fibrosis, and as it progresses, the lungs thicken and are unable to transfer oxygen into the bloodstream ...
Rose Bowl Walk to Benefit Pulmonary Fibrosis Organization Patch.com

all 2 news articles » 


Taylor hopes for new lungs, new life - Richmond County Daily Journal



Taylor hopes for new lungs, new life 
Richmond County Daily Journal
Seven years ago, John Taylor of Cordova was diagnosed with idiopathic pulmonary fibrosis. ?I had never heard of that, didn't understand what it meant,? said Taylor. Idiopathic pulmonary fibrosis is scarring or thickening of the lungs without a known ...

 


Bettendorf football coaching icon Habenicht dies at 77 - Indianapolis Star



Bettendorf football coaching icon Habenicht dies at 77 
Indianapolis Star
Merv Habenicht, one of the most successful high school football coaches in Iowa history, died Wednesday of pulmonary fibrosis. He was 77. Habenicht led Bettendorf to five state championships and compiled a 228-70-1 record before retiring in 2000.
Bettendorf coaching legend dies Quad City Times
Iconic Bettendorf football coach dies cbs4qc.com

all 6 news articles » 


Pulmonary fibrosis hasn't stopped cyclist's pedals - InsideHalton.com



Pulmonary fibrosis hasn't stopped cyclist's pedals 
InsideHalton.com
When Rob Alexander-Carew was diagnosed with idiopathic pulmonary fibrosis, a degenerative lung disease, last July, he refused to give up his exercise routine of indoor cycling. The 39-year-old Oakville resident said that he was determined to struggle ...

 


Stony Brook, NYU in deal with drug firm - Chicago Tribune



Stony Brook, NYU in deal with drug firm 
Chicago Tribune
It calls for the New Brunswick, NJ, company to work with researchers from the schools on an inhalable treatment for the condition, idiopathic pulmonary fibrosis. The disease affects about 200000 Americans each year. It's caused by scar tissue in the ...

and more » 


Promedior moves to Boston, appoints new CEO - Mass High Tech



Mass High Tech
 
Promedior moves to Boston, appoints new CEO 
Mass High Tech
Suzanne L. Bruhn has been named president and CEO at a time when the company is rapidly advancing its product candidates in human clinical trials for diseases involving fibrosis, including idiopathic pulmonary fibrosis (IPF), myelofibrosis, ...
Promedior Appoints President and CEO Private Equity Hub (press release)
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO Xconomy

all 3 news articles »